Emerging global trends and regulatory opportunities in cell therapies for cancer
Kim Watanabe, Sushama Sankpal, Kasey Kime
Harnessing flow cytometry for high-throughput screening in immunotherapy development
Kevin Chen, Jonah Riddell, Raffaello Cimbro
Engineering lipid nanoparticles for lung cancer imaging
Ben Knappett, Blaine McCarthy
Same-section spatial multiomics: a platform for detailed analysis of the solid TME
Emily Neil, Ariadna Pascual
Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies
K Wonnacott, L Pelloso, D Takefman et al
CAR-T manufacturing intensification: the next wave of CAR-T commercialization
A Bersenev, E Kleiren, J Knighton et al
Rapid CAR-T cells: Accelerating manufacturing to enable fast transition of CAR-T cell therapies to the clinic
Tamara Laskowski, Kelly Purpura
CAR-T: Why not me?
Nina Senutovitch, Yanping Guo, Sarwish Rafiq
Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time
Sophia Lollies, Ian Johnston
Targeting EGFR to enhance NKT cell-mediated killing of lung cancer cells
Tonya J Webb, David Ferrick, Stacie Chvatal